CFB
IONS icon

Cullen/Frost Bankers’s Ionis Pharmaceuticals IONS Stock Holding History

Cullen/Frost Bankers’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-168
Closed -$9K – 1106
2020
Q4 		$9K Hold
168
– – ﹤0.01% 921
2020
Q3 		$8K Sell
168
-844
-83% -$46.9K ﹤0.01% 923
2020
Q2 		$60K Buy
1,012
+800
+377% +$44.5K ﹤0.01% 624
2020
Q1 		$10K Sell
212
-44
-17% -$2.45K ﹤0.01% 723
2019
Q4 		$15K Sell
256
-1
-0.4% -$60 ﹤0.01% 838
2019
Q3 		$15K Sell
257
-1,080
-81% -$70.4K ﹤0.01% 777
2019
Q2 		$86K Buy
1,337
+89
+7% +$6.29K ﹤0.01% 487
2019
Q1 		$101K Buy
+1,248
New +$80.5K ﹤0.01% 470

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cullen/Frost Bankers's IONS Position: Q1 2021 in Review

Cullen/Frost Bankers sold out of Ionis Pharmaceuticals (IONS) in Q1 2021, closing a stake of 168 shares — an estimated $9K sold.

Cullen/Frost Bankers first reported a position in IONS in Q1 2019 and held it in 8 quarters. The position peaked at $101K in Q1 2019. 364 funds tracked by Wall St. Rank hold IONS as of Q1 2021.

  • Cullen/Frost Bankers reported no remaining Ionis Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Cullen/Frost Bankers sold 168 Ionis Pharmaceuticals shares in Q1 2021, an estimated $9K.
  • Cullen/Frost Bankers first reported a position in Ionis Pharmaceuticals in Q1 2019 and held it in 8 quarters.
  • Cullen/Frost Bankers's Ionis Pharmaceuticals position peaked at $101K in Q1 2019.
  • 364 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2021.

Based on Cullen/Frost Bankers's 13F filing for Q1 2021, filed 5 May 2021.